Our goal is to achieve breakthroughs in sarcoma research that help improve patient outcomes, and ultimately lead to a cure.

  • Thursday
  • Nov 11
  • 2021

SARC024

Texas Children’s Cancer and Hematology Centers

Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). Click “Read more” for more information about SARC024.

Read more

Meet the people of SARC

Steven Ziemba, PhD, MS, MBA, MLS

Steven Ziemba joined SARC in September 2021 as Research Manager. Steven earned his PhD in Healthcare Administration from Capella University, Minneapolis, MN
Read bio